Comparative efficacy of taletrectinib versus first-generation TKIs in TKI-naïve ROS1+ non-small cell lung cancer: A matching-adjusted indirect comparison
- DOI
- 10.1016/j.lungcan.2026.109538
- Published
- 2026-09
- Container
- Lung Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.lungcan.2026.109538,
title = {Comparative efficacy of taletrectinib versus first-generation TKIs in TKI-naïve ROS1+ non-small cell lung cancer: A matching-adjusted indirect comparison},
author = {Misako Nagasaka and Geoffrey Liu and Maurice Pérol and Wenfeng Chen and Lyudmila Bazhenova and Caicun Zhou},
year = {2026},
journal = {Lung Cancer},
doi = {10.1016/j.lungcan.2026.109538},
url = {https://doi.org/10.1016/j.lungcan.2026.109538}
}RIS
TY - JOUR TI - Comparative efficacy of taletrectinib versus first-generation TKIs in TKI-naïve ROS1+ non-small cell lung cancer: A matching-adjusted indirect comparison AU - Misako Nagasaka AU - Geoffrey Liu AU - Maurice Pérol AU - Wenfeng Chen AU - Lyudmila Bazhenova AU - Caicun Zhou PY - 2026 JO - Lung Cancer DO - 10.1016/j.lungcan.2026.109538 UR - https://doi.org/10.1016/j.lungcan.2026.109538 ER -
APA
Nagasaka, M., Liu, G., Pérol, M., Chen, W., Bazhenova, L., & Zhou, C. (2026). Comparative efficacy of taletrectinib versus first-generation TKIs in TKI-naïve ROS1+ non-small cell lung cancer: A matching-adjusted indirect comparison. Lung Cancer. https://doi.org/10.1016/j.lungcan.2026.109538
Source records
- crossref · retrieved 2026-09-25T07:52:26.504Z